Advertisement

Topics

Nasdaq Stockholm AB: The observation status for Immune Pharmaceuticals Inc. is updated (330/17)

11:16 EST 13 Nov 2017 | FinanzNachrichten

Today, on November 13, 2017, Immune Pharmaceuticals Inc. (the "Company") published a press release with information that the Company provides a compliance plan to satisfy the EU Market Abuse Regula...

Original Article: Nasdaq Stockholm AB: The observation status for Immune Pharmaceuticals Inc. is updated (330/17)

NEXT ARTICLE

More From BioPortfolio on "Nasdaq Stockholm AB: The observation status for Immune Pharmaceuticals Inc. is updated (330/17)"

Advertisement
Quick Search
Advertisement
Advertisement